• Issue

    Journal of Cutaneous Immunology and Allergy: Volume 6, Issue 2

    39-67
    April 2023

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 39-41
  • First Published: 03 April 2023

RESEARCH ARTICLE

Open Access

Usefulness of Gly m 4-specific IgE test in the diagnosis of Rosaceae fruit-oral allergy syndrome caused by Betulaceae pollen sensitization

  • Pages: 42-48
  • First Published: 09 December 2022
Usefulness of Gly m 4-specific IgE test in the diagnosis of Rosaceae fruit-oral allergy syndrome caused by Betulaceae pollen sensitization

The results of study indicadte that, in the subjects sensitized to alder pollen, the Gly m 4-specific IgE test is useful for predicting clinical allergy symptoms caused by Rosaceae fruits, although Gly m 4 is PR-10 of Fabaceae soybean.

CASE STUDY

Open Access

Neutrophilic dermatosis with necrobiotic changes as an unusual manifestation after the first shot of a COVID-19 mRNA vaccine together with a high fever and liver injury

  • Pages: 49-54
  • First Published: 02 September 2022
Neutrophilic dermatosis with necrobiotic changes as an unusual manifestation after the first shot of a COVID-19 mRNA vaccine together with a high fever and liver injury

A histopathological examination of an EN-like lesion with a few pustules revealed dense perivascular and periglandular infiltrates throughout the dermis and subcutis, which were composed of neutrophils, histiocytes, lymphocytes, and a lot of cell debris with marked necrobiotic changes. Immunohistochemically, cytotoxic CD8+ cells were much more common than CD4+ cells in the dense neutrophilic infiltrates. Many CD68+ macrophages were present around the CD8+ cells.

CORRESPONDENCES

Open Access

A case of COVID-19 with pernio-like skin lesions and increased red blood cell distribution width

  • Pages: 55-56
  • First Published: 15 August 2022

Heparin resistance has been observed in patients with active severe COVID-19 infection. The red blood cell distribution (RDW), a component of the complete blood count that reflects cellular volume variation, has been shown to be associated with elevated risk for morbidity and mortality in a wide range of diseases. Cutaneous manifestations, RDW, and levels of LD and D-dimer might be useful biomarkers in triage of patients with COVID-19.

Open Access

Hydroxyzine-induced fixed drug eruption and cross-reaction with oxatomide

  • Pages: 59-60
  • First Published: 15 September 2022

There are a few reports in the literature implicating them in causing fixed drug eruption, the piperazine derivatives. In this case, although eszopiclone for insomnia medicinehas a piperazine ring, no eruption appeared so far. Oxatomide and hydroxyzine not only shared a piperazine ring but also shared two benzene rings via a methine group (=CH–). It was suspected that this shared structural group became an antigenic determinant and resulted in cross-reactivity. Such a unique case has not been reported before.

Open Access

A case of cutaneous Mycobacterium chelonae infection requiring a differential diagnosis of Mycobacterium stephanolepidis infection

  • Pages: 61-62
  • First Published: 08 September 2022
A case of cutaneous Mycobacterium chelonae infection requiring a differential diagnosis of Mycobacterium stephanolepidis infection

Mycobacterium stephanolepidis is a rapidly growing mycobacterium, closely related to Mycobacterium chelonae. It was first reported in 2017, and whether it is infectious to humans is unknown. Here, we report a rare case of cutaneous M. chelonae infection requiring a differential diagnosis of M. stephanolepidis infection.

Open Access

A case of refractory hypertrophic lupus erythematosus on the face whose irreversible skin fibrosis was treated by local full-thickness skin graft under disease control with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine

  • Pages: 63-65
  • First Published: 26 August 2022
A case of refractory hypertrophic lupus erythematosus on the face whose irreversible skin fibrosis was treated by local full-thickness skin graft under disease control with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine

Hypertrophic lupus erythematosus (HLE) remains pose a treatment challenge, and often displays disfiguring scar with cosmetic and/or functional impairment. We report a male case of refractory hypertrophic lupus erythematosus on the face, whose disease activity was controlled with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine. The persisted, irreversible fibrotic skin mass was finally treated with surgical approach using full-thickness skin graft, achieving a favorable cosmetic result.

Open Access

Adult-onset Still's disease following mRNA-1273 Moderna COVID-19 vaccination: A case report

  • Pages: 66-67
  • First Published: 19 October 2022
Adult-onset Still's disease following mRNA-1273 Moderna COVID-19 vaccination: A case report

A 57-year-old woman who was inoculated with the second dose of the mRNA-1273 Moderna COVID-19 vaccine and then developed adult-onset still’s disease as a result.